Autolus Therapeutics plc
AUTL
$1.41
-$0.14-9.03%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
4/1/2025
-
The Fly
4/1/2025
-
GuruFocus
4/1/2025
-
Globe Newswire
3/28/2025
-
Insider Monkey
3/28/2025
-
MarketBeat
3/27/2025
-
Insider Monkey
3/27/2025
-
MarketBeat
3/24/2025
-
GuruFocus
3/24/2025
-
TipRanks Financial Blog
3/24/2025
-
MarketBeat
3/22/2025
-
MarketBeat
3/22/2025
-
MarketBeat
3/22/2025
-
Insider Monkey
3/21/2025
-
Ticker Report
3/21/2025
-
GuruFocus
3/21/2025
-
MarketBeat
3/21/2025
-
MarketBeat
3/21/2025
-
The Fly
Autolus Therapeutics PLC (AUTL) Q4 2024 Earnings Call Highlights: Financial Growth Amid Rising Costs
3/21/2025
-
GuruFocus
3/21/2025
-
GuruFocus
3/20/2025
-
Seeking Alpha: Transcripts
3/20/2025
-
SeekingAlpha
3/20/2025
-
SeekingAlpha
3/20/2025
-
GuruFocus
3/20/2025
-
The Fly
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, March 20, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
44 20 3829 6230
Address
The Mediaworks
191 Wood Lane - White City
London, W12 7FP
191 Wood Lane - White City
London, W12 7FP
Country
Year Founded
Business Description
Sector
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases. The company’s clinical-stage programs include...
more
